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Abstract
Inflammatory bowel diseases involve the dynamic interplay of host genetics, microbiome and 
inflammatory response. Here, we report that NLRP12, a negative regulator of innate immunity, is 
reduced in human ulcerative colitis by comparing monozygotic twins and other patient cohorts. In 
parallel, Nlrp12-deficiency in mice caused increased colonic basal inflammation, leading to a less-
diverse microbiome, loss of protective gut commensal strains (Lachnospiraceae) and increased 
colitogenic strains (Erysipelotrichaceae). Dysbiosis and colitis susceptibility associated with 
Nlrp12-deficency were reversed equally by treatment with antibodies targeting inflammatory 
cytokines or by administration of beneficial commensal Lachnospiraceae isolates. Fecal 
transplants from specific pathogen free reared mice into germ-free Nlrp12-deficient mice showed 
that NLRP12 and the microbiome each contribute to immune signaling that culminates in colon 
inflammation. These findings reveal a feed-forward loop where NLRP12 promotes specific 
commensals that can reverse gut inflammation, while cytokine blockade during NLRP12-
deficiency can reverse dysbiosis.
The healthy intestine is inhabited by trillions of bacteria and has evolved a fine-tuned 
balance between pathogen recognition and commensal tolerance1. In contrast, microbial 
imbalance, referred to as dysbiosis, is highly associated with inflammatory bowel diseases 
(IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), yet IBD treatment is 
limited to immunotherapies. Hence, understanding the host gene-microbiota interaction that 
contributes to colitis holds promise in unveiling novel microbiome-based therapeutic 
options.
A hallmark of IBD is the dysregulated activation of inflammatory cytokines and signaling 
pathways such as the NF-κB, MAPK or STAT family members2. Several innate immune 
receptors and sensors known as NLRs (nucleotide-binding domain, leucine-rich repeat 
proteins or NOD-like receptors) regulate these pathways. NLRs are a family of intracellular 
innate immune sensors that exert either pro- or anti-inflammatory functions. The NLR 
family member NOD2 activates NF-κB, and mutations in NOD2 represent the first genetic 
association with CD susceptibility3, 4. Nod2-deficient mice display gut dysbiosis, which may 
contribute to exacerbated colitis5, 6, 7. Similarly, loss of the NLRP6 inflammasome is 
associated with increased pathogenic colitis-associated microbes8. Although the NLRP12 
inflammasome has been implicated in the recognition of specific infections9, NLRP12 has 
non-inflammasome and anti-inflammatory functions by impeding canonical and non-
canonical NF-κB10, 11, 12, 13. Although NLRP12 serves as negative regulator of 
inflammatory signaling in experimental colitis in mice, its impact on the colonic bacterial 
ecology and translational relevance to humans are completely unknown. Here, we identified 
an additional function for NLRP12 in restricting intestinal inflammation by promoting 
beneficial Lachnospiraceae strains.
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RESULTS
Exacerbated colitis in Nlrp12−/− mice is microbiota-dependent
NLRP12 performs an anti-inflammatory role in experimental colitis12, 13. To determine if 
NLRP12 is clinically relevant to human colitis, we performed a meta-analysis of a paired-
comparison between 10 pairs of monozygotic UC and healthy twins and seven additional 
UC patient gene-profiling studies (Fig. 1a and Supplementary Fig. 1) and found that 
NLRP12 was significantly down-regulated in active UC cohorts compared to healthy 
controls or inactive UC cohorts. In animals, conventionally-raised Nlrp12−/− mice displayed 
more severe colitis compared to wild type mice following the oral administration of 3% 
dextran sodium sulfate (DSS), which induces experimental colitis. These differences include 
significantly increased weight loss, mortality, histology score and clinical disease symptoms 
measured as disease-associated index (DAI), and Nlrp12−/− mice exhibited reduced colon 
length (indication of increased colonic inflammation) (Fig. 1b–c and Supplementary Fig. 
2a–d)12, 13. Additionally, the loss of Nlrp12 resulted in heightened NF-κB, ERK and STAT3 
activation (Supplementary Fig. 2e–g). These findings establish a link between reduced 
NLRP12 expression and human IBD and consolidate NLRP12’s protective role in limiting 
colon inflammation via suppressing excessive immune signaling.
In addition to the association between genetic susceptibility and colon inflammation, 
mounting evidence supports a role for the microbiota during IBD pathogenesis14, 15, 16. To 
assess the impact of the microbiota on the increased colitis susceptibility in Nlrp12−/− mice, 
we subjected germ-free (GF) wild-type and Nlrp12−/− mice to a low-dose 1.5% DSS in 
drinking water due to the reported increased sensitivity of GF mice to DSS17. In contrast to 
conventionally-raised mice, GF-wild-type and GF-Nlrp12−/− mice showed indistinguishable 
weight loss, mortality, DAI, colon length and histology scores following DSS treatment (Fig. 
1d–h). Colons from GF-wild-type and GF-Nlrp12−/− mice showed similar levels of activated 
NF-κB, ERK and STAT3 (Fig. 1i–k). These results implicate a role for the microbiota in 
severe colitis found in Nlrp12−/− mice.
The presence of NLRP12 curtails the activation of inflammatory cell signaling pathways 
induced by bacteria-derived ligands11, 12, 13, 18, which suggests Nlrp12−/− mice may present 
increased basal colonic inflammation in the presence of resident bacteria at the steady state. 
Indeed, colons from naive specific-pathogen free (SPF) Nlrp12−/− mice displayed elevated 
NF-κB p65 and p52 activation compared to controls (Fig. 1l). Of note, this basal level of 
activation was low compared to mice treated with DSS, as these blots required a longer 
exposure time to visualize the proteins. To determine the role of NLRP12 in regulating basal 
colon inflammation in the presence of microbiota, we housed GF-wild-type and GF-
Nlrp12−/− mice in a SPF vivarium for 4 weeks (Fig. 1m). GF-Nlrp12−/− mice colonized for 4 
weeks (exGF-Nlrp12−/−) displayed increased colon NF-κB activation compared to control 
mice (exGF-wild-type) and animals maintained in sterile isolators (i.e., GF-wild-type and 
GF-Nlrp12−/− mice) at steady state (Fig. 1n). These results demonstrate that basally-
activated NF-κB immune signaling pathways require Nlrp12-deficiency and the microbiota 
from mice housed in conventional conditions. C-type lectin antimicrobial peptide REG3γ 
and cathelicidin-related antimicrobial peptide (CRAMP) were increased in the exGF-
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Nlrp12−/− mice compared to exGF-wild-type mice and control GF animals (Fig. 1o–p), 
which agrees with previous work that inflammation promotes antimicrobial peptides 
expression resulting in a dysbiotic intestinal microbiome19. These findings indicate that the 
intestinal microbiota exacerbated colitis in Nlrp12−/− mice.
NLRP12-deficiency results in a dysbiotic microbiome
To determine if NLRP12 alters the microbiome, high throughput 16S rRNA gene sequencing 
analysis was performed on fecal bacterial DNA isolated from untreated wild-type and 
Nlrp12−/− mice that were originally generated from the same heterozygous Nlrp12+/− 
parents and raised in our facilities for more than nine generations. Rarefaction analysis was 
used to compare bacterial diversity within individuals of a group20. Compared to wild-type 
mice, Nlrp12−/− mice harbored a microbiota with significantly reduced diversity (Fig. 2a) 
and a different community composition (Fig. 2b). Comparing within and between group 
dissimilarity indicated that the microbiome difference between the wild-type vs. Nlrp12−/− 
mice was significantly greater than the differences between animals of each genotype (Fig. 
2c, calculated from Fig. 2b). Housing and diet are key factors that can influence the 
intestinal microbiota21; thus, we repeated the microbiome analysis three years later with 
mice housed in a second vivarium with different formula chow and observed similar findings 
(Supplementary Fig. 3a–c). These results demonstrate that Nlrp12−/− mice retained this 
altered microbiome in different housing conditions.
Because the analyzed wild-type and Nlrp12−/− mice had been bred separately for multiple 
generations, it is possible that familial transmission instead of NLRP12-deficiency was 
responsible for the altered microbiome22. Therefore, we analyzed feces from wild-type and 
Nlrp12−/− littermates birthed from the same Nlrp12 heterozygous parents (Nlrp12+/−) and 
housed separately by genotype after weaning (Supplementary Fig. 3d). Compared to wild-
type littermates, Nlrp12−/− mice from this heterozygous mating harbored a microbiota with 
significantly reduced diversity (Fig. 2d) and increased dissimilarity (Supplementary Fig. 3e) 
compared to wild-type littermates.
To establish rigor of the microbiota results, we used high throughput 16S rRNA gene 
sequencing to characterize the microbiome of naive wild-type and Nlrp12−/− mice in three 
mouse cohorts (vivarium 1, vivarium 2 and littermate studies) (Supplementary Tables 1–3) 
and observed a consistent decrease in Bacteroidales, Clostridiales and Lachnospiraceae and 
an increase in Erysipelotrichaceae in the Nlrp12−/− mice compared to wild-type animals 
(Fig. 2e). This is noteworthy, as IBD patients have been reported to display a similar 
microbiome profile14, 16, 23 (Fig. 2f and Supplementary Table 4). Thus, we focused on these 
bacterial groups in further studies.
Fecal transplantation attenuates disease in Nlrp12−/− mice
To determine if the altered microbiome observed in Nlrp12−/− mice is responsible for the 
exacerbated colon inflammation in Nlrp12−/− mice, we conducted microbiota transfer 
studies by cohousing mice, which leads to the exchange of the microbiota through 
coprophagia8, 24, 25. Age-and-sex matched wild-type and Nlrp12−/− mice were either single-
housed (SiHo) or cohoused (CoHo) for six weeks prior to 3% DSS treatment (Fig. 3a). 
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Control single-housed wild-type and Nlrp12−/− mice showed significant differences in 
disease severity (Fig. 3b–f). After receiving DSS, Nlrp12−/− mice that were cohoused with 
wild-type mice (CoHo Nlrp12−/−) displayed reduced disease and immune signaling 
compared to their SiHo Nlrp12−/− littermates (Fig. 3b–i and Supplementary Fig. 4a). 
Moreover, CoHo Nlrp12−/− and wild-type cage-mates were similar in all measurements (Fig. 
3b–i). As a control, cohousing wild-type animals with inflammasome-deficient Asc−/− mice 
failed to ameliorate colitis in DSS-treated Asc−/− mice, but instead increased death, DAI and 
histopathology in wild-type mice as reported (Supplementary Fig. 4b–f)8. This is in contrast 
to improved survival and lessened colitis in CoHo Nlrp12−/− mice and makes Nlrp12-
deficiency the first case where elevated colitis susceptibility resulting from an NLR 
deficiency can be reversed by transferring normal microbiota.
To investigate detailed microbiome changes after cohousing wild-type mice with Nlrp12−/− 
mice, we performed 16S rRNA gene microbiome sequencing analysis on feces from wild-
type and Nlrp12−/− mice before and after cohousing (Fig. 3a). Consistent with Fig. 2, we 
observed significantly different community composition between the wild-type and 
Nlrp12−/− mice before cohousing (Supplementary Fig. 4g–h). After six weeks of cohousing, 
the microbiota composition of the cohoused Nlrp12−/− mice was more similar to that of the 
wild-type mice and distinct from the single-housed Nlrp12−/− littermates (Fig. 3j). The 
microbiome dissimilarity between cohoused and single-housed Nlrp12−/− mice was similar 
to that of control single-housed wild-type vs. Nlrp12−/− mice (Fig. 3k, calculated from Fig. 
3j). Thus, Nlrp12−/− mice cohoused with wild-type mice developed a microbiota that was 
closer in community structure to that of wild-type animals. To assess if the transferred 
microbiota resulted in changes in specific bacteria, we performed a two-way ANOVA test on 
all sequenced fecal bacteria identified by 16S rRNA gene sequencing. The Clostridiales 
order and Lachnospiraceae family were significantly higher in frequency, and 
Erysipelotrichaceae was lower in the cohoused Nlrp12−/− mice compared to the single-
housed Nlrp12−/− mice (Fig. 3l). These data demonstrate that transferred microbiota from 
wild-type mice ameliorated disease susceptibility in Nlrp12−/− mice in a co-housing setting.
The experiments utilizing Nlrp12+/+ and Nlrp12−/− littermate mice and GF animals suggest 
NF-κB dysregulation occurs prior to alterations in the microbiota, as Nlrp12−/− mice 
developed a different microbiome from that of Nlrp12+/+ littermates after weaning (Fig. 2d–
e), and GF Nlrp12−/− mice display increased basal colon inflammation when colonized (Fig. 
1n). However, compared to single-housed Nlrp12−/− mice, cohoused Nlrp12−/− mice 
displayed attenuated NF-κB activation during DSS-induced colitis, suggesting the altered 
microbiota in Nlrp12−/− mice also contributes to heightened NF-κB activation (Fig. 3g). To 
investigate the causality between NF-κB hyperactivation and altered microbiota in Nlrp12−/− 
mice, we performed reciprocal fecal transplantation experiments in which GF wild-type 
mice were reconstituted with the microbiota of SPF Nlrp12−/− mice, and GF Nlrp12−/− mice 
were reconstituted with the microbiota of SPF wild-type mice via oral gavage once a week 
for 3 weeks as described24. The animals were given a one-week rest period where no fecal 
transfer was performed, and the mice were then exposed to DSS in drinking water for 5 
days. Transfer of the fecal microbiota (FM) from an SPF wild-type donor into GF wild-type 
mice (designated as FMwild-type→GF wild-type) resulted in significantly reduced DSS-
induced colitis, survival and disease index, but greater colon length compared to the transfer 
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of FM from an SPF Nlrp12−/− donor into GF Nlrp12−/− mice (FMNlrp12−/−→GF Nlrp12−/−) 
(Fig. 4a–d). However, FMwild-type→GF Nlrp12−/− and FMNlrp12−/−→GF wild-type mice 
exhibited similar weight loss, survival, disease index and colon length, which were less 
severe compared to control FMNlrp12−/−→GF Nlrp12−/− mice (Fig. 4a–d). This indicates 
that Nlrp12−/−-shaped microbiome and genetic deficiency in Nlrp12 are both required to 
produce the fulminant colitis in Nlrp12−/− mice. Next, we examined the contribution of FM 
vs. host genetics on immune signaling pathways (Fig. 4e). As expected, colon samples from 
control FMwild-type→GF wild-type mice exhibited minimal NF-κB and STAT3 activation, 
whereas FMNlrp12−/−→GF Nlrp12−/− samples showed elevated p52, pp65 and pSTAT3. 
Colons from FMNlrp12−/−→GF wild-type and FMwild-type→GF Nlrp12−/− mice showed 
intermediate, but distinct activation patterns. FMNlrp12−/−→GF wild-type colons had 
elevated pp65 similar to FMNlrp12−/−→GF Nlrp12−/− colons, but reduced p52 nuclear 
translocation and STAT3 activation. By contrast, FMwild-type→GF Nlrp12−/− colons showed 
elevated p52 and pSTAT3, but modest pp65 activation. These results indicate that both the 
microbiome in Nlrp12−/− animals and Nlrp12 gene deficiency are required to cause the full 
activation of p52, p65 and STAT3 and fulminant colitis.
Lachnospiraceae suppresses colitis in Nlrp12−/− mice
Figure 3 showed that Clostridiales order and Lachnospiraceae family were significantly 
higher, and Erysipelotrichaceae was lower in Nlrp12−/− mice compared to wild-type mice. 
Lachnospiraceae strains are decreased in CD14, 16, 23, and Lachnospiraceae limits 
experimental C. difficile-induced colitis26. To determine if bacterial groups that are lacking 
in Nlrp12−/− mice can restrict colitis, we inoculated wild-type and Nlrp12−/− mice with 23 
strains of Lachnospiraceae via oral gavage for 21 days followed by one week of rest before 
DSS treatment (Fig. 5a). Mice given Lachnospiraceae and brain-heart infusion (BHI) vehicle 
control, which was used to grow Lachnospiraceae, had similar weight prior to DSS 
treatment (Fig. 5a, left panel). Strikingly, DSS-treated Nlrp12−/− mice given 
Lachnospiraceae displayed reduced colitis including reduced weight loss, DAI, colon 
histopathology and increased colon lengths compared to Nlrp12−/− mice given vehicle 
control (Fig. 5a–d and Supplementary Fig. 5). Proinflammatory cytokines (Fig. 5e) and 
canonical and non-canonical NF-κB, ERK and STAT3 showed similar reductions (Fig. 5f–
h).
To examine whether Lachnospiraceae modulates severity of inflammation by altering the 
composition of the microbiota of Nlrp12−/− mice, we sequenced the microbiome of the mice 
receiving Lachnospiraceae or control BHI. For both wild-type and Nlrp12−/− mice, the 
diversity of the microbiota from Lachnospiraceae-receiving mice was significantly increased 
compared to BHI-treated littermates, although the impact was greater in Nlrp12−/− mice 
(Fig. 5i). UniFrac distance analysis was used to quantify the dissimilarity between bacterial 
communities among the groups. The distance between the BHI-treated Nlrp12−/− mice vs. 
Lachnospiraceae-treated Nlrp12−/− mice was as large as the distance between the control 
BHI-treated wild-type vs. BHI-treated Nlrp12−/− mice (Fig. 5j–k), indicating that the 
microbiome in Lachnospiraceae-treated Nlrp12−/− mice was significantly distinct from that 
of littermate control Nlrp12−/− mice given BHI. Additionally, the dissimilarity distance 
between the BHI-treated wild-type and Lachnospiraceae-treated Nlrp12−/− mice was 
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significantly decreased compared to the distance between the BHI-treated Nlrp12−/− mice 
and Lachnospiraceae-treated Nlrp12−/− mice (Fig. 5k), suggesting that Nlrp12−/− mice 
administered Lachnospiraceae develop a microbiome more reminiscent of wild-type 
animals. Among all the strains sequenced (Supplementary Table. 5), administration of 
Lachnospiraceae promoted the growth of Clostridiales in Nlrp12−/− mice, but significantly 
reduced Erysipelotrichaceae (Fig. 5l). As the abundance of Erysipelotrichaceae was 
increased in the Nlrp12−/− mice, which positively correlated with disease severity (Fig. 3b–
f), administration of Lachnospiraceae may limit colitis in part by suppressing expansion of 
Erysipelotrichaceae.
Hematopoietic NLRP12 expression prevents dysbiosis
Increased intestinal inflammation in Nlrp12−/− mice is driven by both hematopoietic and 
non-hematopoietic components12, 13, but the cellular compartment expressing NLRP12 that 
shapes the intestinal commensals is unknown. To address this, we generated radiation bone 
marrow chimeric mice by lethally irradiating wild-type and Nlrp12−/− mice and then 
transferred bone marrow from wild-type and Nlrp12−/− donors to generate wild-type mice 
containing myeloid cells deficient in Nlrp12 (Nlrp12−/−→wild-type) and Nlrp12−/− mice 
expressing Nlrp12 only in myeloid cells (wild-type→Nlrp12−/−). We then assessed the 
microbiome after a 10-week-reconstituition period (Fig. 6a). As expected, control wild-type 
mice given wild-type bone marrow retained greater microbiota diversity than Nlrp12−/− 
recipients with Nlrp12−/− bone marrow (Fig. 6b). Wild-type mice with Nlrp12−/− bone 
marrow (Nlrp12−/−→wild-type) displayed reduced bacterial diversity compared to wild-
type→wild-type mice. Additionally, transplantation of wild-type bone marrow into 
Nlrp12−/− mice (wild-type→Nlrp12−/−) increased bacterial diversity compared to control 
Nlrp12−/−→Nlrp12−/− mice (Fig. 6b). These results indicate that NLRP12 expression in the 
hematopoietic compartment dominantly shapes the diversity of the intestinal bacteria. 
Analysis of bacterial composition confirmed these findings (Fig. 6c–d).
We next characterized the hematopoietic cells in the colon lamina propria (cLP) that could 
be contributing to increased basal inflammation in Nlrp12−/− mice. Although NLRP12 
suppresses inflammatory pathways in bone marrow-derived macrophages13, 18 and DCs12, 
there is no evidence to support a role for NLRP12 in colonic macrophages and DCs, which 
are phenotypically different from their bone marrow-derived counterparts27. Within the cLP, 
colon resident macrophages are identified as two subsets that express the fractalkine receptor 
(CX3CR1), F4/80 and CD11b with or without coexpression of CD11c. DCs within the cLP 
express CD11c and CD103 and are considered CD11b negative or low (Fig. 6e)28. To 
analyze the impact of NLRP12 on these macrophage and DC populations in the steady state, 
we isolated cLP cells from naive wild type and Nlrp12−/− mice and gated on CD45+I-Ab+ 
cells with differential expression of F4/80, CD11b, CD11c and CD103 by flow cytometry. In 
accordance with increased colonic inflammation in SPF Nlrp12−/− mice, these mice 
displayed a significantly increased frequency of CD11c+CD11blo cells (designated R3 in 
Fig. 6e, left panels) and a modestly increased frequency of CD11cloCD11b+ (R1) and 
CD11c+CD11b+ (R2) populations. These R1–R3 fractions were further stained for F4/80 
and CD103. In wild type and Nlrp12−/− mice, the R1 and R2 populations were found to be 
primarily macrophages, and R3 were DCs (Fig. 6e, right panels). The composite data of 
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multiple animals showed an increased frequency of CD11bloCD11c+F4/80−CD103+ DCs in 
the lamina propria of Nlrp12−/− mice (Fig. 6f). The frequency of 
CD11b+CD11cloF4/80+CD103− and CD11b+CD11c+F4/80+CD103− populations, which 
were characterized as macrophages, were also increased in Nlrp12−/− mice, but this 
difference was not significant (Fig. 6f). These results suggest that Nlrp12 deficiency 
increased CD11bloCD11c+F4/80−CD103+ colonic DCs.
To maintain colon homeostasis, macrophages and DCs in the cLP acquire anti-inflammatory 
phenotypes29 and become anergic to bacterial stimulation27. To test if NLRP12 plays a role 
in maintaining colonic macrophage and DC quiescence, we exposed cLP macrophages and 
DCs from naive wild-type and Nlrp12−/− mice to cecal contents from wild-type animals to 
mimic the cell-resident bacterial interactions in vivo. Consistent with the concept that cLP 
macrophages and DCs are anergic to bacterial stimulation27, cecal content exposure did not 
increase inflammatory cytokine gene expression in wild-type macrophages and DCs with the 
exception of a slight increase in Il23a (encoding p19) expressed by wild-type DCs (Fig. 6g). 
By contrast, cecal contents significantly increased Il6, Tnf, Il12b (encoding p40) and Il23a 
expression in Nlrp12−/− CD11b+CD11c+ macrophages and CD11bloCD11c+ DCs compared 
to wild-type controls (Fig. 6g). Only Tnf was significantly elevated in Nlrp12−/− 
CD11b+CD11clo macrophages after exposure to cecal contents. These results suggest that 
NLRP12 maintains homeostasis in colonic macrophages and DCs in the presence of cecal 
material.
TNF and IL-6 cause microbial dysbiosis in Nlrp12−/− mice
The findings above (Fig. 4) indicate that the Nlrp12 deficiency and Nlrp12−/−-derived 
microbiome resulted in elevated inflammation. We next directly tested if increased 
inflammation could drive microbial dysbiosis. Anti-TNF antibody is a common treatment 
for IBD patients30, while anti-IL-6R antibody has been discussed as a new therapeutic 
strategy for colitis31, 32. We targeted the inflammatory cytokines TNF and IL-6 in vivo by 
injecting mice with anti-TNF and anti-IL-6 receptor (IL-6R) antibodies (Ab) prior to and 
during DSS exposure (Supplementary Fig. 6a–b). Blocking TNF and IL-6 signaling 
ameliorated DSS-induced colitis in Nlrp12−/− mice indicated by significantly improved 
weight gain, survival and clinical scores (Fig. 7a–c), while the impact was less pronounced 
in wild-type controls.
To determine if Ab treatment reversed dysbiosis in Nlrp12−/− mice, we performed 
microbiome analysis before and after Ab treatment. Prior to Ab treatment, naive Nlrp12−/− 
mice displayed significantly altered microbiome compared to wild-type mice 
(Supplementary Fig. 6c–e). However, anti-TNF- and anti-IL-6R-treated Nlrp12−/− mice 
displayed significantly increased intestinal bacterial diversity compared to PBS-treated 
Nlrp12−/− mice (Fig. 7d) and reduced microbiome compositional differences compared to 
wild-type mice (Fig. 7e–f), with elevated Bacteroidales and Clostridiales taxa (Fig. 7g). By 
contrast, PBS-treated Nlrp12−/− mice maintained significantly reduced bacterial diversity, 
Bacteroidales and Clostridiales compared to wild-type mice. These results indicate that 
blocking excessive inflammatory cytokines recovered the altered microbiome and reduced 
colitis in Nlrp12−/− mice.
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DISCUSSION
NLRP12 has a protective role in intestinal inflammation by suppressing canonical and 
noncanonical NF-κB12, 13. In this study, we identified an additional critical role for NLRP12 
by regulating gut microbial communities. IBD-profiling studies revealed that NLRP12 
expression is negatively correlated with active UC. In addition, an imbalance in the intestinal 
microbiota, or dysbiosis, has been linked to IBD pathogenesis14, 15, 16. We reveal a link 
between these two clinical observations by providing direct evidence that NLRP12 promotes 
microbial symbiosis, which results in reduced colitis susceptibility.
Unlike conventionally-raised Nlrp12−/− mice, which are more susceptible to colitis 
compared to similarly raised wild-type animals, Nlrp12−/− mice raised under germ-free 
conditions were indistinguishable from GF-wild-type mice during experimental colitis. This 
indicates interactions between host cells and resident bacteria are required for the severe 
disease susceptibility in Nlrp12−/− mice. Intestinal microbial diversity and human disease 
have a complex reciprocal cause and effect relationship. A reduction of gut microbiome 
richness is a biomarker for human metabolic and inflammatory disorders33, including 
IBD24. Loss of commensal diversity due to genetic alterations34 or an unhealthy diet35 
correlates with exacerbated colitis. Our results indicate that NLRP12 acts a central 
component of this relationship by curtailing excessive inflammatory cytokine production to 
limit intestinal inflammation and maintain commensal diversity and protective microbiota. 
Neutralization of TNF is a current IBD therapy, and targeting IL-6R is being assessed as a 
similar therapeutic approach. Our findings indicate that in addition to suppressing 
inflammatory signaling, targeting these cytokines may also alleviate colitis by reversing 
dysbiosis.
Many protective intestinal bacterial groups are necessary for maintaining gut homeostasis. 
Similar to the microbiota found in CD patients14, we observed a decrease in Bacteroidales 
and Clostridiales (in particular Lachnospiraceae) strains in untreated Nlrp12−/− mice, which 
correlated with a greater sensitivity to DSS-induced colitis. Nod2- or Nlrp6-deficiency 
results in a colitogenic microbiota that can exacerbate colitis5, 6, 7, 8. In contrast, this is the 
first observation where dysbiosis and colitis severity caused by loss of an NLR can be 
reversed by transferring the microbiota from wild-type animals, further supporting our 
conclusion that NLRP12 plays a predominate role in maintaining protective commensal 
bacterial groups and limiting colitogenic strains. In line with this, Nlrp12−/− mice cohoused 
with wild-type mice exhibited elevated intestinal Clostridiales and Lachnospiraceae, 
decreased Erysipelotrichaceae and reduced DSS-induced colitis. Although Lachnospiraceae 
are decreased in IBD patients14, 16, 23, 36, 37 and Clostridium difficile-associated colitis38, 
little is known about how these protective strains impact the host immune system. 
Lachnospiraceae are more enriched in the mucosal folds compared to the central lumen39. 
The spatial location of Lachnospiraceae favors their interaction with lamina propria residual 
immune cells, which suggests Lachnospiraceae may function as an immune regulator to 
prevent enteric pathogen adhesion/colonization. Lachnospiraceae are also major producers 
of the short chain fatty acid (SCFA) propionate in the human gut40, which promotes 
peripheral regulatory T cell generation41, 42. Loss of Lachnospiraceae species in the 
Nlrp12−/− mice may result in reduced SCFA production, which could contribute to elevated 
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inflammation in Nlrp12−/− mice. Moreover, there is a negative correlation between intestinal 
Lachnospiraceae and Erysipelotrichaceae. Erysipelotrichaceae have been linked to elevated 
TNF levels and chronic intestinal inflammation in SIV-infected animals and HIV-infected 
patients receiving antiretroviral therapy43, 44, which suggest these organisms appear to be 
highly inflammatory. In agreement with these findings, we showed that Erysipelotrichaceae-
enriched fecal microbiota from Nlrp12−/− mice induced more NF-κB and STAT3 activation. 
Lachnospiraceae may provide a protective function in part by suppressing over-growth of 
intestinal Erysipelotrichaceae. Accompanied by the human gene profile outcome where 
mucosal NLRP12 expression is reduced in active colitis, our results suggest that 
Lachnospiraceae may be therapeutic when applied to UC subjects with reduced NLRP12 
expression.
In sum, reciprocal fecal transplantation experiments, cohousing and bacteria transfer 
experiments collectively indicate that the interaction between aberrant immune signaling and 
dysbiotic microbiota in Nlrp12−/− animals does not proceed in a one-way linear trajectory, 
but instead in a vicious feed-forward cycle in which increased inflammation driven by loss 
of NLRP12 expression produces a proinflammatory microbiota that further escalates 
inflammation (Supplementary Fig. 7).
METHODS
Mice
All animal procedures were approved by the University of North Carolina Chapel Hill 
(UNC) Institutional Animal Care and Use Committee (IACUC) according to US National 
Institutes of Health Guide for the Care and Use of Laboratory Animals. Animal numbers 
were empirically determined to optimize numbers necessary for statistical significance based 
on our previous reports utilizing these disease models (minimum of 4–7 animals/group). 
Animals were excluded if exhibiting signs of disease not associated with the conditions of 
the colitis (e.g., fight wounds and malocclusion). No randomization method was used due to 
the single-housing and co-housing strategy required for the microbiome studies, ad libitum 
administration of DSS in drinking water and use of littermate controls.
Wild type (WT) C57BL/6J mice were obtained from Jackson laboratory and house-raised at 
UNC for at least 9 generations. Nlrp12−/− and Asc−/− mice are on C57BL/6J background 
after at least 9 generations of backcross. Conventionally raised mice were bred and housed 
in specific-pathogen-free (SPF) conditions, and germ-free (GF) animals were generated and 
housed in the National Gnotobiotic Rodent Resource Center of North Carolina at Chapel 
Hill or in the Center for Gastrointestinal Biology and Disease, Gnotobiotic Core at North 
Carolina State University. For cohousing experiments, 4-week old mice originating from the 
same breeders were divided for either single-housed (SiHo) or cohoused (CoHo) with age- 
and sex-matched mice for 6 weeks. CoHo mice were compared to their SiHo littermates as 
controls. For conventionalization study, GF animals were transferred into SPF condition and 
housed for 4 weeks. Conventionalized (exGF) animals were compared to mice kept in the 
GF condition as controls. For the reciprocal fecal transplantation study, GF wild-type or 
Nlrp12−/− mice were orally gavaged once a week for three weeks with a PBS suspension of 
feces derived from SPF wild-type or Nlrp12−/− mice following the previously described 
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protocol24. The mice were given DSS 1 week after the final gavage. For adoptive bone 
marrow transplantation study, wild-type and Nlrp12−/− chimeric mice were generated as 
previously described12. No antibiotics were used during the reconstitution phase, and fecal 
DNA was collected 10 weeks after the transplantation for microbiome analysis.
Experimental Colitis
Experimental colitis was initiated by treating mice with 1.5%–3% dextran sulfate sodium 
(DSS) (36,000–50,000 M.Wt, MP Biomedicals) in autoclaved drinking water for 5 days as 
indicated. DSS was then replaced by normal autoclaved water for 6–7 days. Body weight 
was monitored daily, and disease-associated index (DAI) was determined by an investigator 
blinded to experimental conditions on day 8 post-DSS treatment according to the following 
parameters: 1) Weight loss (0 points=0% weight loss from baseline, 1 point=1–5% weight 
loss, 2 points=5–10% weight loss, 3 points=10–20% weight loss and 4 points=more than 
20% weight loss); 2) Rectal bleeding (0 points=negative, 2 points=positive hemoccult test 
and 4 points=gross bleeding); and 3) Stool consistency (0 points=normal, 2 
points=semiformed stool and 4 points=liquid that adhere to the anus). The sum of these 3 
parameters results in the total DAI ranging from 0 (healthy) to 12 (maximal activity of 
colitis)12.
Histopathology
Colons were Swiss-rolled, fixed in 10% neutral-buffered formalin and paraffin embedded 
and processed for histological analysis. Five-micron-thick colon sections were stained with 
hematoxylin and eosin (H&E) and semi-quantitatively scored for histopathology by a board-
certified veterinary pathologist in a blind manner. Histology score represented the sum of 
each histological alterations outlined below. This system assessed inflammation, epithelial 
defects, area of inflammation, area of epithelial defect, crypt atrophy and dysplasia/
neoplasia by giving each parameter a separate score (0–4) for severity and extent as 
previously described12.
Immunoblotting
Colons were excised, opened longitudinally and washed with cold PBS. The distal-most-3 
cm section of each colon was collected and mechanically homogenized in NE-PER Nuclear 
and Cytoplasmic Extraction Reagent (Thermo Scientific) containing Complete Protease 
Inhibitor and PhosphoStop (Roche) per manufacturer’s protocol. Cytosolic and nuclear 
lysates were subjected to SDS-PAGE and immunoblotting. The following primary 
antibodies were use for immunoblot analysis: anti-pIκBα (Ser32) (14D4) (cat. no 2859); 
anti-pIKKα/β (Ser176/180) (16A6) (cat. no. 2697); anti-pp65 (Ser536) (93H1) (cat. no. 
3033); anti-NIK (cat. no. 4994); anti-pERK1/2 (Thr202/Tyr204) (D13.14.4E) (cat. no. 
4370); anti-p65 (D14E12) (cat. no. 8242); anti-pSTAT3 (Tyr705) (cat. no. 9131); and anti-
STAT3 (79D7) (cat. no. 4904) (Cell Signaling Technology); anti-p52 (C-5) (cat. no. 
sc-7386); anti-ERK1 (C-16) (cat. no. sc-93); anti-ERK2 (C-14) (cat. no. sc-154); anti-
CRAMP (G-1) (cat. no. sc-166055) and anti-Actin-HRP (C-11) (cat. no. sc-1615) (Santa 
Cruz Biotechnology); anti-REG3γ (cat. no. ab198216) (Abcam); and anti-Histone H3 (cat. 
no. 07-690) (Millipore). Goat anti-rabbit-HRP (cat. no. 111-035-144) and goat anti-mouse-
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HRP (cat. no. 115-035-146) (Jackson Laboratories) were used as secondary antibodies. 
Protein densitometry were quantified by Image J software.
Colon Explant Cultures
Colons were excised, washed several times in cold PBS containing 2x penicillin/
streptomycin (Sigma Aldrich) and cultured for 15 hours in RPMI media (Gibco) containing 
2x penicillin/streptomycin at 37°C. Supernatants were collected, centrifuged to clear debris 
and assessed for cytokines by Luminex Bio-Plex System per manufacturers instructions.
Fecal DNA Extraction
Fecal samples were collected from live mice, snap-frozen and stored at −80°C. DNA was 
isolated by incubating fecal material at 65°C for 30 min in Lysing Matrix E tubes (MP 
Biomedicals) containing 200 mM NaCl, 100 mM Tris, 20 mM EDTA (pH 8.0), SDS and 
proteinase K (Qiagen). Phenol:Choloroform:Isoamyl alcohol (Invitrogen) was added, and 
the samples were homogenized at 4°C for 3 min using a bead beater homogenizer. The 
samples were centrifuged at 8000 rpms for 3 min at 4°C, and the supernatant was incubated 
with Phenol:Chloroform (Invitrogen) for 10 min at room temperature. The samples were 
centrifuged at 13,000 rpms for 5 min at 4°C, and the aqueous phase was incubated with 
isopropanol and 3M sodium acetate, pH 5.2, at −20°C for 15 hrs to precipitate DNA. The 
precipitated DNA was collected by centrifugation at 13000 rpm at 4°C for 20 min, washed 
twice with 100% cold ethanol and resuspended in TE buffer. The DNA was further purified 
using a DNeasy Blood and Tissue Kit (Qiagen) according to the manufactures protocol.
16S rRNA Gene Sequencing and Data Analysis
Fecal DNA samples were amplified by PCR using barcoded primer pairs targeting the V1–
V2 region of the 16S gene. PCR amplicons were sequenced at the V1–V2 region using 
Roche 454 for the vivarium #1 study37, and the same V1–V2 region was sequenced using an 
Mi-Seq Illumina sequencer38 for all other described experiments. The resulting bacterial 
sequence fragments were clustered into Operational Taxonomic Units (OTUs) and aligned to 
microbial genes with 97% sequence similarity from Greengenes Database using UCLUST 
method in QIIME. Bacterial taxa summarization and rarefaction analyses of microbial 
diversity or compositional differences (dissimilarity value indicated by Unweighted UniFrac 
Distance) were calculated in QIIME (1.8.0) as previously described20 using QIIME scripts 
(including pick_open_reference_otus.py, summarize_taxa.py, alpha_rarefaction.py, 
jackknifed_beta_diversity.py and make_distance_boxplots.py). PCoA plots indicating 
compositional difference were generated by QIIME script, make_2d_plots.py. Each point 
represents one mouse, and the ellipses represent the interquartile range (IQR) during the 
rarefaction analyses45 (see http://www.wernerlab.org/teaching/qiime/overview for scripts 
details). All 16S rRNA microbiome sequences have been deposited in the European 
Nucleotide Archive (http://www.ebi.ac.uk/ena) and QIITA (https://qiita.ucsd.edu). The 
accession codes are listed in the Data Availability section.
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Mouse colonic lamina propria macrophage and dendritic cells isolation and stimulation
Mouse colons were opened longitudinally and washed with cold PBS to remove the fecal 
contents. Pooled colons from 2 mice were further cut into 1.5 cm pieces and washed twice 
with 30 ml of HBSS containing 10% FBS and 2mM EDTA on an orbital shaker at 250 rpms 
for 30 min at 37°C. After washing, the colons were finely minced and digested with 20 ml of 
HBSS containing 10% FBS, 1.5 mg/ml Type VIII Collagenase (C2139; Sigma-Aldrich) and 
40 μg/ml DNase I (4527; Sigma-Aldrich) at 200 rpms for 20 min at 37°C. After the 
digestion, the digested colonic lamina propria (cLP) cells were filtered through a 100 μm 
strainer, centrifuged at 1,500 rpm for 5 min at 4 °C and resuspended in 2 ml MACS buffer 
for flow cytometric analysis or fluorescence-activated cell sorting (FACS)46.
For flow cytometric analysis, cLP cells were incubated with mouse Fcγ II/III receptor 
blocker (553141; BD Pharmingen) for 15 min on ice and were then stained with the 
following labeled antibodies for 30 min on ice: Brilliant Violet 421-conjugated anti-CD45 
(103133; Biolegend), PE-conjugated anti-IAb (553552; BD Pharmingen), APC-Cy7-
conjugated anti-CD11c (117324; Biolegend), PE-Cy7-conjugated anti-CD11b (101216; 
Biolegend), APC-conjugated anti-CD103 (17-1031-80; eBioscience), and Alexa Fluor 488-
conjugated anti-F4/80 (123120; Biolegend). Samples were washed twice in MACS buffer 
and were analyzed on a BD LSR II flow cytometry at the UNC Flow Cytometry Core 
Facility. Dead cells and doublets were excluded from the cLP mononuclear based on 
appropriate forward and side scatter plots. Antigen-presenting cells (APC) were defined as 
CD45+I-Ab+. Macrophage and dendritic cell (DC) populations were firstly categorized by 
the expression of CD11b and CD11c and then further characterized by CD103 and F4/80 
expression as previously described46.
For cLP macrophage and DC FACS separation and ex vivo stimulation, CD11b+ and 
CD11c+ microbeads (Miltenyi Biotec) were used to enrich CD11b+ or CD11c+ positive 
cells. The enriched cells were stained with labeled antibodies aforementioned. Stained cells 
were sorted to purify the indicated population at the UNC Flow Cytometry Core Facility. 
Sorted macrophages and DCs were seeded in a 96-well plates (0.5~1X105 cells per well) 
with 200 μl RPMI medium containing 10% FBS. For cecal content stimulation, cecal 
contents were generated from wild-type mice as described elsewhere47 and were added to 
the cell culture medium at a 1:200 dilution for 3 hours. Total RNA was then isolated by 
TRIzol according to the manufacturer’s instructions (Thermo Fisher Scientific) for qRT-PCR 
analysis.
Design of Lachnospiraceae specific primers
Lachnospiraceae strains were identified utilizing an adapted version of the plate wash PCR 
technique48. This allowed for rapid screening by PCR using phylotype specific primers of 
the 16S rRNA gene to screen selective media plates in order to identify conditions that 
enrich for specific bacteria. To generate Lachnospiraceae specific primers the near full 
length 16S rRNA gene sequence from 34 bacterial strains were used to generate 
CLUSTALW multiple-sequence alignments. The 16S rRNA gene sequences used were the 
following: 9 of the most represented bacterial sequences from the murine large intestine 
found in Berry, et al.49 (Akkermansia muciniphila, Alistipes finegoldii, Bacteroides 
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acidifaciens, Barnesiella intestinihominis, Clostridium propionicum, Enterococcus faecalis, 
Eubacterium siraeum, Oscillibacter valericigenes, Ruminococcus flavefaciens), 4 Firmicutes 
(Clostridium difficile, Enterococcus faecalis, Lactobacillus murinus, and Staphylococcus 
xylosus), 6 Lachnospiraceae (Clostridium aldenense, Clostridium bolteae, Clostridium 
citroniae, Clostridium indolis, Clostridium propionicum, Clostridium xylosus), 3 
Lachnospiraceae strains isolated in Reeves et al.26 (D4, G11, and E7), and 12 of the most 
represented Lachnospiraceae-classified OTUs from Reeves, et al.26. Areas of homology 
between Lachnospiraceae sequences that were not homologous to other Firmicutes and 
Bacteroidetes were used to create 4 Lachnospiraceae specific 16S rRNA forward gene 
primers: Lachno419F (5′ –GAC GCC GCG TGA GTG AAG AAG TAT- 3′), Lachno428F 
(5′ –GTA AAG CTC TAT CAG CAG GGA AGA- 3′), Lachno481F (5′ –GAC GGT ACC 
TGA CTA AGA AGC CC- 3′), and Lachno462F (5′ –GTC CAC AGG ACT TTG GAC 
GG- 3′). The primer LachF (5′-CC GCA TAA GCG CAC AGC- 3′) from Reeves, et al.26 
was also utilized in this study. These forward primers were used with the 16S rRNA reverse 
gene primer 1492R (5′-GGT TAC CTT GTT ACG ACT T- 3′) for PCR amplification. One 
Lachnospiraceae specific reverse primer was also created: Lachno1261R (5′-TCG CTT 
CCC TTT GTT TAC GC- 3′), which was used with the 16S rRNA forward gene primer 8F 
(5′-AGA GTT TGA TCC TGG CTC AG- 3′) for PCR amplification. The specificity and 
coverage of the Lachnospiraceae primers (Supplementary Table 6) was obtained using the 
Ribosomal Database Project Probe Match tool (https://rdp.cme.msu.edu/probematch/
search.jsp accessed on May 19, 2012). Additionally, primers were tested with Gram-negative 
bacteria Bacteroides fragilis Escherichia coli; Gram-positive bacteria Lactobacillus murinus, 
Staphylococcus aureus, Staphylococcus pneumonia; Clostridium difficile strain VPI 10463 
to ensure specificity to Lachnospiraceae.
PCR was performed with 1 μl of template DNA (approximately 100 ng), 20 pmol of each 
primer, 8mM dNTP master mix (Promega-U1511), 1 unit GoTaq DNA polymerase 
(Promega- M3005), PCR buffer (Promega- M3005) and water in a total of 25 μl per reaction. 
PCR reaction was performed under the following cycling conditions: 95°C for 2 min, 30 
cycles of 95°C for 30 sec, annealing at 57°C for 45 sec, and extension at 72°C for 90 sec, 
72°C for 10 min.
Bacterial isolation and selective growth conditions
Three of the Lachnospiraceae isolates (Lachnospiraceae D4, G11, and E7) used in this study 
were reported previously26. The remaining 20 strains were isolated from murine cecal 
contents, cecal tissue and stool. Mouse stool was collected into a sterile tube directly from a 
restrained mouse and immediately transferred into an anaerobic chamber (Coy Industries, 
Grass Lake, MI). Ceca from C57BL/6 mice were collected in a sterile manner and 
immediately transferred into an anaerobic chamber. A sterile scalpel was used to open the 
cecum and separate cecal content and cecal tissue. Cecal content was added to a sterile tube 
and diluted into anaerobic 1X phosphate-buffered saline (PBS). Using a sterile syringe 2 ml 
of PBS was gently injected into the cecum to remove any additional cecal content. The cecal 
tissue was then added to 1 ml of anaerobic PBS and placed into a sterile container for tissue 
homogenization (50 μm pore size) using a Medimachine tissue homogenizer (BD 
Biosciences). The tissue was grinded for 15 seconds and homogenized tissue was used for 
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plating. The cecal contents, cecal tissue homogenization and stool was serial diluted in 
anaerobic PBS and plated in duplicate onto brain heart infusion agar (BD Biosciences) with 
0.01% cysteine (BHI).
A variety of media conditions were used to enrich for Lachnospiraceae isolates. Bacterial 
growth from the first agar plate was collected and genomic bacterial DNA was isolated using 
an Easy-DNA (Invitrogen) kit. Using the Lachnospiraceae specific primers and PCR 
conditions described above, we identified several media conditions that were enriched for 
Lachnospiraceae strains. Once a media condition was identified that enriched for 
Lachnospiraceae strains, single colonies from the duplicate plate were used to inoculate 1 ml 
of BHI + 5% fetal bovine serum (FBS) into a sterile 96-well plate. These cultures were 
grown anaerobically for 3 days at 37°C, and then 1 μl of the liquid culture was used as a 
template for the PCR reaction described above. The Lachnospiraceae-specific primers from 
(Supplementary Table 6) were used to identify potential Lachnospiraceae isolates. If any of 
the primers used yielded a successful PCR reaction, 50 μl of the corresponding culture was 
plated for single colonies anaerobically on BHI + 5% FBS for one to three days at 37°C. A 
single colony was used to inoculate a 5 ml BHI + 5% FBS culture that grew anaerobically 
for one to three days at 37°C. This culture was used to create 20% final concentration 
glycerol stocks of all the isolates that were stored at −80°C.
The following media conditions were used to isolate Lachnospiraceae strains in this study: 
BHI + 5% FBS; BHI + 1 μg/mL aztreonam + 10 μg/mL colistin + 2 μg/mL gentamicin; and 
BHI + 0.5 μg/mL ampicillin + 2 μg/mL erythromycin + 0.25 μg/mL vancomycin. Single 
colonies from the duplicate plate were used to inoculate 1 ml of BHI + 5% FBS. Specific 
media conditions used to isolate each Lachnospiraceae strains are defined in (Supplementary 
Table 7).
Taxonomic classification of bacterial isolates
Genomic DNA was isolated using an Easy-DNA (Invitrogen) kit. PCR reaction conditions 
were described above and PCR product cleanup was performed using ExoSAP-IT 
(Affymetrix) per the manufactures protocol. Near full-length 16S rRNA amplicons were 
sequenced at the University of Michigan DNA Sequencing Core using primers 8F (5′-AGA 
GTT TGA TCC TGG CTC AG- 3′), 515F (5′-GTG CCA GCM GCC GCG GTA- 3′), 
E939R (5′-CTT GTG CGG GCC CCC GTC AAT TC- 3′), and 1492R (5′-GGT TAC CTT 
GTT ACG ACT T- 3′). CLUSTALW multiple-sequence alignments were generated for each 
isolate and a near-full length 16S rRNA gene consensus sequence was obtained. The 
consensus sequence was taxonomically classified using the RDP classifier (https://
rdp.cme.msu.edu/classifier/classifier.jsp accessed between 6-29-2012 and 3-7-2013)50. 
Bacterial strains that classified to the family Lachnospiraceae were used in this study 
((Supplementary Table 7)).
Mouse Colonization with Lachnospiraceae Bacteria
Mice were orally gavaged with a mixture containing the 23 Lachnospiraceae stains (~1X108 
bacteria) described above in brain-heart infusion broth (BHI) twice a week for 3 weeks. BHI 
broth was used as vehicle control. The mice were given DSS 1 week after the final gavage.
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In vivo anti-IL-6R and anti-TNF Treatment
Mice were given 2 mg/kg body weight of anti-IL-6R (Tocilizumab, Genentech) and anti-
TNF (Infliximab, Janssen Biotech) via intraperitoneal injection twice a week for four weeks 
prior to DSS exposure and during the 11 day DSS treatment period. Fecal DNA was 
collected from wild-type littermates and Nlrp12−/− littermates before and after the 4-week 
antibody treatment period, but prior to DSS treatment.
Metadata Study of Human NLRP12 profiling and microbiome changes in UC Patients
Raw data from 8 NCBI GEO human UC studies were renormalized and analyzed by 
Genespring GX (Agilent Tech). The following studies were used: GSE22619, GSE42911, 
GSE14580, GSE16879, GSE13367, GSE65114, GSE21231 and GSE57945. In the summary 
panels, the healthy group includes the samples from healthy participants and normal un-
inflamed tissues of the patients, the active group includes the samples from the patients’ 
inflamed tissues and the inactive group includes un-inflamed tissue samples of patients in 
remission due to the treatment (anti-TNF, steroids and others).
For microbiome changes in IBD patients, we downloaded the raw 16S rRNA gene 
sequencing file published by Dirk Gevers et al.14 from the open-source microbiome 
deposition site: QIITA (https://qiita.ucsd.edu/) under study ID: 1939. This file includes 16S 
microbiome sequencing results from 28 healthy controls, 63 colonic Crohn’s disease 
patients (cCD), 156 ileal Crohn’s disease patients (iCD) and 24 UC patients. Raw 
sequencing data was reanalyzed as aforementioned. Significantly altered bacterial strains 
were identified by comparing IBD (cCD, iCD and UC) patients against healthy participants.
Statistical Analysis
Statistical analysis was performed with GraphPad Prism 6 software. Significance between 
two groups was determined by unpaired, two-tailed Student’s t test, and significance 
between multiple groups was determined using one-way analysis of variance (ANOVA) with 
Fisher’s LSD test. A paired, two-tailed Student’s t test was used to compare NLRP12 
mRNA between monozygotic twins in (Fig. 1a). A two-way ANOVA test was used to 
identify the significantly changed microbial groups among all strains identified by 16s 
microbiome sequencing between different experimental conditions. Statistical significance 
for survival studies was determined by Log-rank (Mantel Cox) test. For immunoblots and 
dot plots, one dot or lane represents one mouse. Microbiome compositional dissimilarity 
was displayed by PCoA plots and quantified by UniFrac Distance values, and significant 
separation of the microbiome composition was determined by ANOSIM test using Qiime 
1.8.0. The distribution of the UniFrac Distance values were displayed in Tukey’s boxplots, 
which display the first (bottom of the box) and third quartiles (top of the box), the median 
(the line inside the box) and 1.5 interquartile range of the upper or lower quartile (whiskers). 
For all statistical comparisons, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 and n.s. 
means no significance. The error bar represents mean ± standard error of the mean (SEM).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Microbiota differentiates colitis severity between WT and Nlrp12−/− mice. (a) NLRP12 gene 
expression between 10 pairs of monozygotic healthy and UC twins (left panel). Composite 
of 8 NCBI GEO ulcerative colitis (UC) studies (right panel) (Supplementary Fig. 1 shows 
the other seven individual studies). (b) Body weight and (c) percent survival of 
conventionally-raised mice treated with 3% DSS (WT, n=41; Nlrp12−/−, n=42), compiled 
from 4 independent experiments. (d) Body weight, (e) percent survival, (f) disease-
associated index (DAI) and (g) colon length of germ-free (GF) WT (n=18) and Nlrp12−/− 
(n=19) mice given 1.5% DSS, compiled from 2 independent experiments. (h) Blinded 
histopathology scoring of colons (n=6/group). (i–k) Representative immunoblots and 
densitometry of distal colon proteins from DSS-treated GF mice from 2 independent 
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experiments (n=7/group). (l) Immunoblots and densitometry of distal colon cytosolic 
(CYTO) and nuclear (NUC) protein fractions from untreated specific-pathogen free (SPF) 
mice (n=9/group). (m) Schematic comparing GF and conventionalized (exGF) mice. (n–p) 
Immunoblots and densitometry of distal colon proteins from untreated GF and exGF mice 
(n,p, n=4/group; o, n=3/group). One dot or one lane represents one mouse. Error bars show 
SEM. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, and n.s. means no significance 
by two-tailed paired t test (a, left panel), unpaired t test (a, right panel, b, d, f–l, n–p) or 
Log-rank (Mantel Cox) test (c and e).
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Figure 2. 
Nlrp12-deficiency results in a dysbiotic colonic microbiome. (a) Bacterial diversity and (b) 
unweighted UniFrac principal coordinate analysis (PCoA) showing microbiota 
compositional differences between WT (n=9) and Nlrp12−/− (n=8) mice from one 
experiment in vivarium #1. A second independent experiment was performed in vivarium #2 
(Supplementary Fig. 3). Each symbol represents one mouse. (c) Quantification of UniFrac 
distance from (b) indicated as dissimilarity values. (d) Bacterial diversity of Nlrp12+/+ 
(n=10) and Nlrp12−/− (n=14) littermates, compiled from 2 independent experiments. (e) 
Consistently altered intestinal bacterial groups in Nlrp12−/− vs. WT mice from experiments 
described in (a–d and Supplementary Fig. 3). (f) Venn diagram showing overlapped 
microbiota changes between Nlrp12−/− vs. WT mice and IBD vs. healthy individuals 
(Supplementary Table 4 provides detailed information). Error bars denote SEM. *p<0.05, 
**p<0.01, ***p<0.001 and ****p<0.0001 determined by two-tailed unpaired t test (a, d, and 
e) or ANOSIM test (c). The Tukey’s boxplot indicates the first (bottom of the box) and third 
quartiles (top of the box). The line inside the box represents the median, and the ends of the 
whiskers indicate the 1.5 interquartile ranges of the upper or lower quartiles (c).
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Figure 3. 
Nlrp12−/− mice co-housed with WT mice display attenuated colitis. (a) Schematic of 
cohousing (CoHo) vs. single-housing (SiHo) strategy, fecal microbiome sequencing and 
DSS treatment of WT and Nlrp12−/− mice. (b) Body weight and (c) percent survival († 
indicates statistical significance between SiHo WT vs. SiHo Nlrp12−/−, and * indicates 
significance between SiHo Nlrp12−/− vs. CoHo Nlrp12−/−), (d) DAI and (e) colon length of 
littermate mice treated as illustrated in (a) (SiHo WT, n=16; SiHo Nlrp12−/−, n=18; CoHo 
WT, n=12; CoHo Nlrp12−/−, n=12), compiled from 3 independent experiments. (f) 
Histopathology scoring of colons (n=10/group). (g–i) Representative immunoblots and 
densitometry of distal colon proteins from the single- and cohoused mice from 3 
independent experiments. (j) PCoA plot showing fecal microbial composition after 
cohousing (n=9/group). (k) Quantification of UniFrac distance between mice from (j) after 
cohousing, indicated as dissimilarity values. (l) Significantly altered strains identified by 
two-way ANOVA test from all sequenced bacteria in SiHo WT, SiHo and CoHo Nlrp12−/− 
mice (n=9/group). One dot or one lane represents one mouse. Error bars show SEM. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 and n.s. means no significance determined 
using two-tailed unpaired t test (b), Log-rank (Mantel Cox) test (c), one-way ANOVA 
Fisher’s LSD test (d–i), ANOSIM test (k) and two-way ANOVA (l).
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Figure 4. 
Transferring microbiota from Nlrp12−/− mice induces colonic inflammation. (a) Body 
weight, (b) percent survival, (c) DAI and (d) colon length of GF WT vs. GF Nlrp12−/− mice 
reconstituted with fecal material (FM) from SPF WT or Nlrp12−/− mice and treated with 
DSS (FMWT→GF WT, n=11; FMNlrp12−/−→GF WT, n=10; FMWT→GF Nlrp12−/−, n=9; 
and FMNlrp12−/−→GF Nlrp12−/−, n=9), compiled from 2 independent experiments. (e) 
Immunoblots and densitometry of distal colon proteins from mice described in (a–d). Error 
bars show SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 and n.s. indicates no 
significance determined using two-tailed unpaired t test (a, e), Log-rank (Mantel Cox) test 
(b) and one-way ANOVA Fisher’s LSD test (c–d).
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Figure 5. 
Administration of Lachnospiraceae suppresses colitis in Nlrp12−/− mice. (a) Body weight of 
WT and Nlrp12−/− mice administered Lachnospiraceae (Lachno) or BHI vehicle (left panel) 
and DSS (right panel), with (b) DAI and (c) colon length after DSS treatment (WT BHI, 
n=24; WT Lachno, n=33; Nlrp12−/− BHI, n=22; Nlrp12−/− Lachno, n=22), compiled from 3 
independent experiments. (d) Histopathology scoring of BHI- or Lachno-treated mice given 
DSS (WT BHI, n=4; WT Lachno, n=4; Nlrp12−/− BHI, n=5; Nlrp12−/− Lachno, n=4). (e) 
Colon explant culture cytokines (WT BHI, n=9; WT Lachno, n=9; Nlrp12−/− BHI, n=14; 
Nlrp12−/− Lachno, n=8), and (f–h) representative immunoblots with densitometry of distal 
colon proteins from DSS-treated mice given BHI or Lachno from 3 independent experiments 
(n=7/group). (i) Bacterial diversity and (j) PCoA plot showing microbiome compositional 
differences quantified by (k) UniFrac distances among the mice administered Lachno or 
BHI prior to DSS (WT BHI, n=7; WT Lachno, n=8; Nlrp12−/− BHI, n=7; Nlrp12−/− Lachno, 
n=8). (l) Significantly altered strains among all identified intestinal bacteria by 16s rRNA 
gene sequencing following Lachno administration. One dot or one lane represents one 
mouse. Error bars show SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 and n.s. 
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means no significance determined using unpaired t test (a, i), one-way ANOVA Fisher’s 
LSD test (b–h), ANOSIM test (k) and two-way ANOVA (l).
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Figure 6. 
NLRP12 expression by hematopoietic cells prevents intestinal dysbiosis. (a) Schematic 
illustrating bone-marrow transplantation (BMT) and fecal DNA collection for microbiome 
analysis. (b) Bacterial diversity, (c) PCoA plot and (d) UniFrac distance plots showing 
microbiome compositional differences in WT and Nlrp12−/− mice after BMT (n=8/group), 
compiled from 2 independent experiments. One dot represents one mouse. (e) 
Representative concatenated flow cytometry plots, and (f) quantification of colonic lamina 
propria macrophage and DC subpopulations in SPF mice. Each dot contains pooled cells 
isolated and sorted from the colons of 2–3 mice. (g) RT-qPCR of proinflammatory cytokines 
expressed by colon resident macrophages (9 technical replicates/group) and DCs (6 
technical replicates/group) stimulated with cecal contents, compiled from 2 independent 
experiments. Error bars show SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 and n.s. 
means no significance determined using two-tailed unpaired t test (b, f and g) and ANOSIM 
test (d).
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Figure 7. 
Anti-IL-6R and anti-TNF suppresses colitis and restores the missing bacterial groups in 
Nlrp12−/− mice. (a) Body weight, (b) percent survival († indicates statistical significance 
between WT PBS vs. Nlrp12−/− PBS; * indicates significance between Nlrp12−/− PBS vs. 
Nlrp12−/− Ab) and (c) DAI of DSS-treated WT and Nlrp12−/− mice injected i.p. with anti-
IL-6R and anti-TNF antibodies (Ab) or PBS (n=13/group), compiled from 3 independent 
experiments. (d) Intestinal microbial diversity, and (e) PCoA showing microbiota 
compositional differences in Ab-treated WT and Nlrp12−/− mice (n=6/group). (f) 
Quantification of UniFrac distances from (e). (g) Significantly altered groups from 
sequenced bacteria in Ab- vs. PBS-treated animals. Error bars show SEM. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 and n.s. indicates no significance determined by two-
tailed unpaired t test (a and d), Log-rank (Mantel Cox) test (b), one-way ANOVA Fisher’s 
LSD test (c), ANOSIM test (f) or two-way ANOVA (g).
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